Skip to main content

Preliminary Report on Neonatal Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Chandigarh Experience

The Indian Journal of Pediatrics volume 77, pages 969–973 (2010)Cite this article

Abstract

Objective

To establish newborn screening in Indian scenario that could lay a framework for future such initiatives. Three disorders namely, congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH) and glucose-6-phosphate dehydrogenase deficiency (G-6-PDD) were selected for a preliminary study for newborn screening.

Methods

Heel-prick blood samples were collected from live-born neonates at 24–48 h of birth as a part of a screening program after prior written consent from the parents. Blood levels of glucose-6-phosphate-dehydrogenase enzyme (G-6-PD), thyroid-stimulating hormone (TSH) and 17-α-OH progesterone (17-OHP) were measured using DELFIA time resolved fluoroimmunoassay.

Results

Six thousand eight hundred and thirteen (6,813) neonates (86.3%), out of a total of 7,893 live births in our institute during the period May’2007 through July’2009, were screened for CAH, CH and G6PD deficiency. Major reason for missing samples was early discharge of the neonates and admission to the neonatal intensive care unit. G-6-PD deficiency was confirmed in 61 cases, congenital hypothyroidism (CH) in 2 cases and congenital adrenal hyperplasia (CAH) in 1 neonate, accounting for an incidence of 1/112 for G-6-PDD, 1/ 3400 for CH and 1/6813 for CAH.

Conclusions

Preliminary data on prevalence of various genetic disorders viz. G-6-PDD, CH and CAH in the population of this region revealed that G-6-PDD is most prevalent disorder followed by CH and CAH. More efforts need to be undertaken to create awareness and emphasis on significance of preventive testing to make screening a successful program in India.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Choudhuri T, Sengupta S. Inborn errors of metabolism—an Indian perspective. Int J Hum Genet. 2006;6:89–91.

    Google Scholar 

  2. ICMR. Collaborating centers and Central coordinating unit. Multicentric study on genetic causes of mental retardation in India. Indian J Med Res. 1991;94:161–9.

    Google Scholar 

  3. Verma IC, Bijarnia S. The burden of genetic disorders in India and a framework for community control. Community Genet. 2002;5:192–6.

    CAS  Article  PubMed  Google Scholar 

  4. Dutta R. ICMR to conduct first nationwide newborn screening for genetic disorders. Express HealthCare Management. 1st–15th September 2005.

  5. Scriver CR, Beaudet AL, Valle D, Sly WS. The metabolic and molecular basis of inherited disease. 6th ed. New York: McGraw-Hill; 1989;1165–80.

    Google Scholar 

  6. Ramadevi AR, Naushad SM. Newborn screening in India. Indian J Pediatr. 2004;71:157–60.

    Article  Google Scholar 

  7. Ramadevi AR, Rao A. Neonatal screening in India. ICMR Report 1989.

  8. Bhasin MK. Genetics of castes and tribes of India: glucose-6-phosphate dehydrogenase deficiency and abnormal haemoglobins (HbS and HbE). Int J Hum Genet. 2006;6:49–72.

    CAS  Google Scholar 

  9. Olgemoller B, Roscher AA, Liebel B, Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab. 2003;88:5790–4.

    Article  PubMed  Google Scholar 

  10. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968;26–7.

    Google Scholar 

  11. The Changing Moral Focus of Newborn Screening. An ethical analysis by the President’s Council on bioethics. 2008. Washington, DC. www.bioethics.gov.

  12. Committee on Genetics. Issues in newborn screening. Pediatrics. 1992;89:345–9.

    Google Scholar 

  13. Neonatal Guidelines 9. Newborn screening. British Columbia Reproductive Care Program, November, 1999; 1–5.

  14. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117:2290–303.

    Article  PubMed  Google Scholar 

  15. Newborn Screening Practitioner’s Manual. The Mountain States Genetics Network. 2003 www.mostgene.org.

  16. Toublanc JE. Guidelines for neonatal screening programs for congenital hypothyroidism. Acta Paediatr Suppl. 1999;432:13–4.

    Article  Google Scholar 

  17. Amar HSS. Screening for congenital hypothyroidism in Southeast Asia. J Paediatr Obstet Gynaecol. 1997;1:5–9.

    Google Scholar 

  18. Kaye CI, Committee on Genetics. Introduction to the newborn screening fact sheets. Pediatrics. 2006;118:1304–12.

    Article  PubMed  Google Scholar 

  19. Low LCK, Lin HJ, Cheung PT, Lee FT, Chu SY, Kwok TL, et al. Screening for congenital hypothyroidism in Hong Kong. Aust Paediatr J. 1986;22:53–6.

    CAS  PubMed  Google Scholar 

  20. American Academy of Pediatrics. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics. 1993;91:1203–9.

    Google Scholar 

  21. Lott JA, Sardovia-Iyer M, Lee KK. Age-dependent cutoff values in screening newborns for hypothyroidism. Clin Biochem. 2004;37:791–7.

    CAS  Article  PubMed  Google Scholar 

  22. Lafranchi S. Hypothyroidism. In: Behrman RE, Kleigman RM, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed. Philadelphia: Saunders; 2004;1872–9.

    Google Scholar 

  23. Tripathy V, Reddy BM. Present status of understanding on the G6PD deficiency and natural selection. J Postgrad Med. 2007;53:193–202.

    CAS  Article  PubMed  Google Scholar 

  24. Newborn Blood-Spot Screening. HGSA-RACP Newborn Screening Joint Subcommittee. HGSA Policy Statement 2004. www.hgsa.com.

  25. Wilcken B, Wiley V. Newborn screening. Pathology. 2008;40:104–15.

    Article  PubMed  Google Scholar 

  26. Padilla CD, Therrell BL. Newborn screening in the Asia Pacific region. J Inherit Metab Dis. 2007;30:490–506.

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The authors would like to acknowledge the complete financial assistance extended by Chandigarh Administration for this study. All neonates were screened free of cost.

Contributions

Kaur G: Design and plan of the study.

Srivastav J: Data Analysis, Calculation of prevalence and Preparation of manuscript.

Jain S: Neonatologist responsible for follow-up and management of high risk neonates.

Chawla D: Neonatologist responsible for follow-up and management of high risk neonates.

Chavan B.S: Design and plan of the study

Atwal R: Biochemical analysis of 17α-OH Progesterone, neonatal TSH and G6PD.

Randhawa G: Pre-test counseling to all parents signifying the importance of screening and consent taking in prescribed Performa.

Kaur A: Pre test counseling to all parents signifying the importance of screening and consent taking in prescribed Performa.

Prasad R: Evaluation of data and preparation of final manuscript.

Conflict of interest

None

Role of funding source

To establish neonatal screening program in a government organization to identify metabolic disorders in asymptomatic phase and prevent associated physical and mental handicap.

Author information

Affiliations

  1. Genetic Centre, Government Medical College & Hospital, Sector 32, Chandigarh, India, 160031

    Gurjit Kaur, Jyoti Srivastav, Bir S. Chavan, Rajiv Atwal, Gurpreet Randhawa & Avneet Kaur

  2. Department of Pediatrics, Government Medical College & Hospital, Chandigarh, India

    Suksham Jain & Deepak Chawla

  3. Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Rajendra Prasad

Authors
  1. Gurjit Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jyoti Srivastav
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suksham Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deepak Chawla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bir S. Chavan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rajiv Atwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gurpreet Randhawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Avneet Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rajendra Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gurjit Kaur.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kaur, G., Srivastav, J., Jain, S. et al. Preliminary Report on Neonatal Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Chandigarh Experience. Indian J Pediatr 77, 969–973 (2010). https://doi.org/10.1007/s12098-010-0150-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-010-0150-x

Keywords

  • Neonatal screening in India
  • Neonatal screening
  • Genetic disorders in India